Safety Alerts & Recalls
What does this mean?
At this time, there have been no reports of health problems with this recalled lot of Invega 6 mg tablets. However, since the recalled tablets are coated with a different color and do not meet manufacturing standards, you may wish to check your prescription to see if your tablets were involved in the recall. Check your bottle to see if you are taking Invega 6 mg tablets and if the tablets are coated incorrectly with a pink color. If you think your tablets may be involved in the recall or if you do not know, please return your bottle to your pharmacist to examine and possibly exchange.
If you have any questions or concerns about this recall, please follow up with your doctor or pharmacist. If you think you may be experiencing side effects from Invega, please contact your doctor as soon as possible.
Recall on a Single Lot of Invega Extended Release 6 mg Tablets
Global Supply Pharmaceutical Group and Janssen Cilag are recalling a single log of Invega Extended-Release Tablets, 6 mg, with the product code NDC 50458-551-01. Lot number 9KG024 (Exp 11/10) is being recalled because the tablets in this lot were coated pink when the approved color for the 6 mg tablets is beige.
Invega contains the active ingredient paliperidone. Invega is primarily used for the treatment of schizophrenia. No other lots or strengths of Invega were involved in this recall.
For more information, please visit: more information here